Low expression of GRM4 is associated with poor prognosis and tumor immune infiltration in glioma.

Hai FanDongming YanXingyue FangLiumin XiaoMengjie LiangHaolin WuGuohua ZhuDangmurenjiafu GengQibing Liu

Published in: The International journal of neuroscience (2024)

GRM4 may have a substantial impact on the infiltration of immune cells and serve as a valuable prognostic biomarker in gliomas.

Keyphrases